140 related articles for article (PubMed ID: 37964132)
1. Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?
Ko MK; Kwak YK; Choi BO; Jeun SS; Park JS; Ahn S; Song JH
J Neurooncol; 2023 Nov; 165(2):321-328. PubMed ID: 37964132
[TBL] [Abstract][Full Text] [Related]
2. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
[TBL] [Abstract][Full Text] [Related]
3. Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma.
Hottinger AF; DeAngelis LM; Yahalom J; Abrey LE
Neurology; 2007 Sep; 69(11):1178-82. PubMed ID: 17846417
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma.
Suzuki Y; Imoto N; Ishihara S; Fujiwara S; Ito R; Sakai T; Yamamoto S; Sugiura I; Kurahashi S
Intern Med; 2022 May; 61(9):1345-1352. PubMed ID: 34670884
[TBL] [Abstract][Full Text] [Related]
5. Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?
Omuro A; Taillandier L; Chinot O; Sierra Del Rio M; Carnin C; Barrie M; Soussain C; Tanguy ML; Choquet S; Leblond V; Hoang-Xuan K;
J Neurooncol; 2011 Aug; 104(1):323-30. PubMed ID: 21170569
[TBL] [Abstract][Full Text] [Related]
6. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy.
Song J; Samant R; Jay M; Chaudry H; Fan XY; MacDonald D; Bence-Bruckler I; Nair V
Support Care Cancer; 2020 Nov; 28(11):5363-5369. PubMed ID: 32140974
[TBL] [Abstract][Full Text] [Related]
7. Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial.
Herrlinger U; Schäfer N; Fimmers R; Griesinger F; Rauch M; Kirchen H; Roth P; Glas M; Bamberg M; Martus P; Thiel E; Korfel A; Weller M
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1815-1821. PubMed ID: 28434043
[TBL] [Abstract][Full Text] [Related]
8. Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma.
Walburn T; Grover NS; Shen CJ; Ranganathan R; Dittus C; Beaven AW; Wang AZ; Wang K
Leuk Lymphoma; 2021 Jan; 62(1):68-75. PubMed ID: 32935601
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
10. Role of radiation therapy in primary central nervous system lymphoma : KROG 14-20 Collaborative Study of Brain and Lymphoma Committee.
Koh HK; Kim IH; Kim TM; Lim DH; Oh D; Cho JH; Kim WC; Kim JH; Chung WK; Jeong BK; Kang KM; Hong S; Suh CO; Kim IA
J Neurooncol; 2017 Dec; 135(3):629-638. PubMed ID: 28939931
[TBL] [Abstract][Full Text] [Related]
11. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.
Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N
Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).
Nelson DF
J Neurooncol; 1999 Jul; 43(3):241-7. PubMed ID: 10563430
[TBL] [Abstract][Full Text] [Related]
13. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
14. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
[TBL] [Abstract][Full Text] [Related]
15. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.
Nguyen PL; Chakravarti A; Finkelstein DM; Hochberg FH; Batchelor TT; Loeffler JS
J Clin Oncol; 2005 Mar; 23(7):1507-13. PubMed ID: 15735126
[TBL] [Abstract][Full Text] [Related]
16. [A single-center, retrospective analysis of relapse and progression patterns of primary central nervous system lymphoma: can whole brain radiotherapy be replaced?].
Qin Y; Liu R; Zhang X; Zhang W; Ren C; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):499-506. PubMed ID: 37202184
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma.
Wu SY; Braunstein SE; Rubenstein JL; Sneed PK
Cureus; 2023 Feb; 15(2):e34817. PubMed ID: 36915845
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma.
Foreman BE; Mullikin TC; Floyd SR; Kelsey CR; Patel MP; Peters KB; Kirkpatrick JP; Reitman ZJ; Vaios EJ
Neurooncol Adv; 2023; 5(1):vdad097. PubMed ID: 37706200
[TBL] [Abstract][Full Text] [Related]
19. Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs.
Nieder C; Leicht A; Motaref B; Nestle U; Niewald M; Schnabel K
Am J Clin Oncol; 1999 Dec; 22(6):573-9. PubMed ID: 10597741
[TBL] [Abstract][Full Text] [Related]
20. Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience.
Iwabuchi M; Shibamoto Y; Sugie C; Ayakawa S; Ogino H; Baba F
J Radiat Res; 2016 Mar; 57(2):164-8. PubMed ID: 26661856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
